Confirmed positive sample from Prowess (NZ) > Australia and International Horse Racing news updated daily
www.thoroughbrednews.com.au
Racing Victoria (RV) Stewards have received a report from Racing Analytical Services Limited (RASL) confirming that a prohibited substance was detected in a pre-race urine sample collected from the Roger James and Robert Wellwood trained racehorse, Prowess (NZ).
The report relates to a pre-race urine sample taken from Prowess prior to the mare starting in the TAB Champions Stakes (Race 😎 over 2000 metres, at Flemington Racecourse on 11 November 2023.
RASL reported that the urine sample was shown to contain Phenylbutazone, Oxyphenbutazone and Gamma-hydroxyphenylbutazone (a non- steroidal anti-inflammatory and its metabolites) which is a prohibited substance on raceday in accordance with the Australian Rules of Racing.
The Australian Racing Forensic Laboratory (ARFL) also reported that it had detected Phenylbutazone, Oxyphenbutazone and gamma-hydroxyphenylbutazone within the reserve portion of the urine sample.
Phenylbutazone is a non-steroidal anti-inflammatory agent. It has analgesic (pain relieving), anti-inflammatory and fever suppression properties and is registered for use in horses by the Australian Pesticides and Veterinary Medicines Authority. The substance is, however, a prohibited substance under the Australian Rules of Racing when detected in a sample taken from a horse at a race meeting or trial (including an official trial or a jump-out for the purpose of obtaining a permit to start in a race).
RV Stewards initially informed Mr James and Mr Wellwood of the irregularity on 22 December 2023. Mr James and Mr Wellwood were informed on 5 February 2024 of the confirmatory findings and that Stewards are continuing their investigation.
Note - Prowess finished 6th in the Group 1 Mackinnon Stakes (TAB Champions Stakes) at Flemington on November 11th.
ThoroughbredNEWS News Desk